News tagged with tumor response
CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer
Dec 01, 2009 |
not rated yet |
0
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University ...
Search results for tumor response
'Self-seeding' of cancer cells may play a critical role in tumor progression
Dec 24, 2009 |
5 / 5 (4) |
0
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers ...
Enzyme necessary for development of healthy immune system
Dec 22, 2009 |
not rated yet |
0
Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by ...
Pancreatic tumors are marked for immunotherapy
Nov 30, 2009 |
not rated yet |
0
Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.
Scientists discover genetic pattern that indicates early-stage lung cancer
Dec 01, 2009 |
4 / 5 (1) |
0
Wistar Institute researchers and collaborators from the University of Pennsylvania and New York University have identified immune system markers in the blood which indicate early-stage lung tumors in people at high risk for ...
Sonic Hedgehog variations linked to recurrence, survival and response to therapy of bladder cancer
Dec 09, 2009 |
not rated yet |
0
Genetic variations in the Sonic Hedgehog pathway increase the likelihood of recurrence, reduce survival time and limit response to therapy for people with non-muscle invasive bladder cancer, scientists from The University ...
Drug shows positive responses, low side-effects in multiple myeloma
Dec 07, 2009 |
not rated yet |
0
NEW ORLEANS ― The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers ...
Clinical trial advances new approach to re-sensitizing breast cancer
Dec 13, 2009 |
not rated yet |
0
A new drug cocktail might be the right mix to fight breast cancer after it becomes resistant to standard therapy. Details of a new study supporting this approach suggest it's possible to re-sensitize tumors thus allowing ...
Figitumumab has anti-tumor activity in Ewing's sarcoma
Dec 23, 2009 |
not rated yet |
0
A preliminary study of the anticancer drug figitumumab has found that it has antitumour activity in Ewing's sarcoma—a cancer which affects mainly teenage boys. The results have led to the drug's progression to a Phase 2 trial ...
Research yields new agent for some drug-resistant non-small cell lung cancers
Dec 23, 2009 |
5 / 5 (1) |
0
The ability to make, test, and map the atomic structure of new anti-cancer agents has enabled a team of Dana-Farber Cancer Institute scientists to discover a compound capable of halting a common type of drug-resistant ...
Obesity linked with poorer breast cancer outcomes
Dec 10, 2009 |
not rated yet |
0
Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.
List of search results for tumor response
